These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6541723)

  • 1. [Effective combined therapy of selective beta 1-adrenergic antagonist and selective beta 2-adrenergic agonist in a patient with bronchial asthma and hypertrophic cardiomyopathy].
    Yukawa T; Numao T; Motojima S; Fukuda T; Ikemori R; Makino S; Shimizu T; Hayashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Apr; 22(4):318-23. PubMed ID: 6541723
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term selective beta 1-blockade therapy for a patient with anthracycline-induced cardiomyopathy].
    Okamoto M; Miyazaki H; Tsuzuki M; Ino T; Ezaki K; Hirano M
    Rinsho Ketsueki; 1995 Nov; 36(11):1305-10. PubMed ID: 8691573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic beta-stimulant therapy: a possible etiopathogenic factor for hypertrophic cardiomyopathy].
    Speca G; Core A; Pardi L
    G Ital Cardiol; 1993 Jul; 23(7):723-8. PubMed ID: 8104836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bradycardia after beginning therapy with metoprolol and paroxetine].
    König F; Häfele M; Hauger B; Löble M; Wössner S; Wolfersdorf M
    Psychiatr Prax; 1996 Sep; 23(5):244-5. PubMed ID: 8992519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-selective beta-adrenergic therapy in a patient with asthma and hypertrophic obstructive cardiomyopathy.
    Smith SC; Spector SL
    Chest; 1981 Jul; 80(1):103-5. PubMed ID: 7195790
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of bronchial asthma with small doses of papaverine combined with beta stimulators].
    Krasnowska M; Jankowska R
    Pneumonol Pol; 1982; 50(1-2):21-4. PubMed ID: 7122246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bronchial asthma -- to set the measuring rod higher. Combination therapy defines asthma control anew].
    MMW Fortschr Med; 2003 Nov; 145(46):46-7. PubMed ID: 14699833
    [No Abstract]   [Full Text] [Related]  

  • 8. Salmeterol: a long-acting beta 2-agonist.
    D'Alonzo GE; Tolep K
    J Am Osteopath Assoc; 1998 Apr; 98(4):216-8, 221-31. PubMed ID: 9594486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma.
    Mendes ES; Horvath G; Campos M; Wanner A
    J Allergy Clin Immunol; 2008 Mar; 121(3):700-4. PubMed ID: 18086493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertrophic cardiomyopathy with a combination of carnitine and beta blockaders. Review of the literature. Description of a clinical case and long-term follow up].
    Ferro M; Crivello R; Gianotti A; Conti M
    Clin Ter; 1993 Aug; 143(2):109-13. PubMed ID: 7900952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adding a prolonged action beta-2-agonist].
    Magnan A
    Rev Pneumol Clin; 2003 Sep; 59(4):257-60. PubMed ID: 14705612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between an alpha-adrenergic antagonist and a beta 2-adrenergic agonist in bronchial asthma.
    Shiner RJ; Molho MI
    Chest; 1983 Apr; 83(4):602-6. PubMed ID: 6831946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
    J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchial asthma. Patient management still has deficits].
    MMW Fortschr Med; 2001 Jul; 143(30):50-2. PubMed ID: 11524993
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol.
    Leor J; Levartowsky D; Sharon C; Farfel Z
    Am Heart J; 1988 Jul; 116(1 Pt 1):206-7. PubMed ID: 3394625
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma guidelines.
    Jack D
    Thorax; 1997 Jul; 52(7):665; author reply 665-6. PubMed ID: 9246148
    [No Abstract]   [Full Text] [Related]  

  • 19. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In children hospitalized for asthma exacerbations, does adding ipratropium bromide to albuterol and corticosteroids improve outcome?
    Hayday K; Stevermer JJ
    J Fam Pract; 2002 Mar; 51(3):280. PubMed ID: 11978242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.